Pharmaceutical assessment of the rationale of the application of chemotherapy schemes containing immunotherapeutic drugs in the treatment of classical Hodgkin's lymphoma
The use of new chemotherapy regimens for Hodgkin lymphoma, containing immunotherapeutic drugs, such as brentuximab vedotin, is an urgent direction in the development of modern oncohematology. The inclusion of these drugs in programs of financial support for hematological oncology patients by the sta...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Ukrainian |
| Published: |
The State Expert Center of the Ministry of Health of Ukraine
2023-06-01
|
| Series: | Фармацевтичний журнал |
| Subjects: | |
| Online Access: | https://pharmj.org.ua/index.php/journal/article/view/1361/1269 |